Chry Monyrath, Smelyanskaya Marina, Ky Mom, Codlin Andrew J, Cazabon Danielle, Tan Eang Mao, Creswell Jacob
Cambodia Anti-Tuberculosis Association, Phnom Penh and Cambodia, Phnom Penh 12250, Cambodia.
Stop TB Partnership, TB REACH, 1218 Geneva, Switzerland.
Trop Med Infect Dis. 2020 Feb 15;5(1):27. doi: 10.3390/tropicalmed5010027.
Despite the World Health Organization recommending the use of rapid molecular tests for diagnosing tuberculosis (TB), uptake has been limited, partially due to high cartridge costs. Other infectious disease programs pool specimens to save on diagnostic test costs. We tested a sputum pooling strategy as part of a TB case finding program using Xpert MTB/RIF Ultra (Ultra). All persons were tested with Ultra individually, and their remaining specimens were also grouped with 3-4 samples for testing in a pooled sample. Individual and pooled testing results were compared to see if people with TB would have been missed when using pooling. We assessed the potential cost and time savings which different pooling strategies could achieve. We tested 584 individual samples and also grouped them in 153 pools for testing separately. Individual testing identified 91 (15.6%) people with positive Ultra results. One hundred percent of individual positive results were also found to be positive by the pooling strategy. Pooling would have saved 27% of cartridge and processing time. Our results are the first to use Ultra in a pooled approach for TB, and demonstrate feasibility in field conditions. Pooling did not miss any TB cases and can save time and money. The impact of pooling is only realized when yield is low.
尽管世界卫生组织建议使用快速分子检测来诊断结核病(TB),但其采用率一直有限,部分原因是检测试剂盒成本高昂。其他传染病项目通过合并样本以节省诊断检测成本。作为结核病病例发现项目的一部分,我们测试了一种痰液合并策略,使用Xpert MTB/RIF Ultra(Ultra)检测。所有人员均先单独使用Ultra进行检测,其剩余样本还会与3至4个样本合并在一起,用于混合样本检测。比较单独检测和混合检测结果,以查看使用合并样本检测时是否会遗漏结核病患者。我们评估了不同合并策略能够实现的潜在成本节约和时间节省。我们检测了584个单独样本,并将它们分成153组进行单独检测。单独检测发现91人(15.6%)的Ultra检测结果呈阳性。通过合并样本检测策略,发现所有单独检测呈阳性的结果也均为阳性。合并样本检测可节省27%的试剂盒和检测时间。我们的结果首次表明将Ultra用于结核病合并样本检测方法,并证明了在现场条件下的可行性。合并样本检测未遗漏任何结核病病例,且可节省时间和金钱。只有在检出率较低时,合并样本检测的作用才能得以体现。